Quote | RAPT Therapeutics Inc. (NYSE:RAPT)
Last: | $ |
---|---|
Change Percent: | -3.44% |
Open: | $31.42 |
Close: | $30.07 |
High: | $31.42 |
Low: | $29.60 |
Volume: | 304,090 |
Last Trade Date Time: | 02/12/2020 04:43:49 pm |
News | RAPT Therapeutics Inc. (NYSE:RAPT)
2024-03-07 11:25:14 ET More on RAPT Therapeutics RAPT Therapeutics: Positive Data, But I Think They're Overvalued For Now H.C. Wainwright cuts RAPT to neutral, cites delays due to clinical hold J.P. Morgan cuts RAPT to neutral, recommends against buying dip S...
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
Message Board Posts | RAPT Therapeutics Inc. (NYSE:RAPT)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $RAPT News Article - RAPT Therapeutics Announces the Appointment of Michael Listgarten | whytestocks | investorshangout | 05/03/2023 5:40:50 PM |
whytestocks: $RAPT News Article - RAPT Therapeutics Strengthens Leadership Team with Two New Key Hir | whytestocks | investorshangout | 09/28/2022 7:26:04 PM |
whytestocks: $RAPT News Article - RAPT Therapeutics Announces Biomarker Data from Phase 1b Trial of | whytestocks | investorshangout | 03/28/2022 12:50:53 PM |
whytestocks: $RAPT News Article - RAPT Therapeutics Reports Fourth Quarter and Year End 2021 Financi | whytestocks | investorshangout | 03/10/2022 1:30:59 PM |
whytestocks: $RAPT News Article - RAPT Therapeutics to Participate in the 11th Annual SVB Leerink He | whytestocks | investorshangout | 02/09/2022 3:55:52 PM |
News, Short Squeeze, Breakout and More Instantly...
RAPT Therapeutics Inc. Company Name:
RAPT Stock Symbol:
NYSE Market:
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigat...
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflamm...
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (NASDAQ:RAPT), a clinical-stage, immunology-based therap...